PANTOPRAZOLE Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses

PANTOPRAZOLE Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses

Pantoprazole

 

IUPAC nomenclature

(RS)-6-(Difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzo[d]imidazole

Classification

  • Proton pump inhibitors

 

Physiochemical Properties

S. NO. PHYSICAL AND CHEMICAL PROPERTIES
1 Molecular weight 383.4 g/mol
2 Physical appearance Off-white solid
3 Melting point 139-140oC
4 Solubility Freely soluble in water
5 Octanol/water partition coefficient 2.05
5 Presence of ring Benzimidazole, pyridine
6 Number of chiral centers Not present

 

 

Mechanism of Action

  • Pantoprazole is a prodrug which requires protonation via an acidic environment to get activated form Sulphenamide.
  • Sulphenamide covalently binds with cystien residues via disulfide bridges on the α subunit of H/K ATPaseenzyme system.
  • Thereby it inhibits the H+/K+ ATPase pump which in turn inhibits the gastric acid secretion or formation of hydrochloric acid in parietal cells

 

Structure Activity Relationship

General structure activity of Heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]Pyridine derivatives acting as acid pump antagonists can be summarized as:

  • The inhibitory property of drugs depends on hydrophobic group substituted at the left side ortho-position of the phenyl ring.
  • Increase in hydrophobic value increases the activity.
  • Increasing the GTCI value decreases the activity.
  • Small molecule substitutions may participate in hydrophobic interaction as well as steric interactions. [1]

 

Method of synthesis

I. Synthesis of 5-(difluoromethoxy)-2-mercaptobenzimidazole:

i. 4-(difluoromethoxy)-aniline is reacted with acetic anhydride to get N-(4-(difluoromethoxy)phenyl)acetamide.

ii. It is then treated with HNO3 followed by reaction with NaOH3 in methanol to get N-(4 (difluoromethoxy)phenyl)acetamide.

iii. After hydrogenation and acidification, the desired compound is formed.

II. Synthesis of 2-chloromethyl-3,4-dimethoxy-pyridinium chloride:

i. 4-chloro-3-methoxy-2-methylpyridine-N-oxide reacted with NaOCH3 followed by reaction with acetic anhydride and treatment with sodium hydroxide followed by chlorination to get the desired compound.

III. Synthesis of Pantoprazole:

i. Both the compounds formed in I and II are reacted together to get pantoprazole.  [2]

 

Medicinal Uses

Pantoprazole is used for treatment of:

  • Stomach ulcers
  • Active duodenal ulcers
  • Active benign gastric ulcer
  • GERD
  • Erosive esophagitis
  • Zollinger-Errison syndrome
  • pylori eradication

 

Side Effects

Side effects of pantoprazole are:

  • Abdominal pain
  • Nausea
  • Constipation
  • Headache
  • Low magnesium blood level
  • Irregular heartbeat
  • Muscle spasms
  • Seizures
  • Lupus
  • Diarrhea
  • Blood in stool

 

MCQs

Q.1 What can be the correct IUPAC nomenclature of Pantoprazole?

a) 2-(diphenylmethoxy)-N,N-dimethylethanamine

b) (RS)-6-(Difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzo[d]imidazole

c) (RS)-1-[(4-chlorophenyl)- phenyl-methyl]-4- [(4-tert-butylphenyl) methyl] piperazine

d) (R)-(+)-2-([3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl)-imidazole

Q.2 Which amongst the following statements is/are incorrect related to the General structure activity of Heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]Pyridine derivatives acting as acid pump antagonists?

I. Increasing the GTCI value decreases the activity.

II. Small molecule substitutions may participate in hydrophobic interaction as well as steric interactions.

a) I

b) I, II

c) II

d) None

Q.3 Types of rings present in the structure of PANTOPRAZOLE?

I. Furan

II. Pyridine

III. Benzimidazole

IV. Phenyl

a) I, II

b) I, IV

c) II, IV

d) II, III

Q.4 Side effects of drug PANTOPRAZOLE is/are?

a) Abdominal pain

b) Constipation

c) Muscle spasms

d) All of the above

Q.5 Match the following drugs with their correct molecular weight-

i. Pantoprazole A. 166.24 gm/mol
ii. Chlorcyclizine B.240.34 gm/mol
iii. Edrophonium C. 383.4 gm/mol
iv. Pheniramine D. 300.8 gm/mol

a) i-A, ii-B, iii-C, iv-D

b) i-C, ii-A, iii-B, iv-D

c) i-C, ii-D, iii-A, iv-B

d) i-A, ii-C, iii-D, iv-B

Q.6 An example of drug from class Proton pump inhibitor drug?

a) Norepinephrine

b) Tolazoline

c) Pantaprazole

d) Phenylephrine

Q.7 Octanol/water partition coefficient of pantoprazole is?

a) 2.05

b) 3.2

c) 4.6

d) 1.6

 

 

 

 

 

For More Standard and Quality Question Bank you can Join Our Test Series Programme for GPAT, NIPER JEE, Pharmacist Recruitment Exam, Drug Inspector Recruitment Exams, PhD Entrance Exam for Pharmacy

Participate in Online FREE  GPAT  TEST: CLICK HERE

  Participate in Online FREE  Pharmacist  TEST: CLICK HERE 

Participate in Online FREE  Drug Inspector  TEST: CLICK HERE 

Participate in CSIR NET JRF Mock Test

Participate GATE Mock Test

 

 

ANSWERS

1-b

2-d

3-d

4-d

5-c

6-c

7-a

 

REFERENCES

[1] Agarwal N, Bajpai A, Gupta SP. A quantitative structure-activity relationship and molecular modeling study on a series of heteroaryl-and heterocyclyl-substituted imidazo [1, 2-a] pyridine derivatives acting as acid pump antagonists. Biochemistry Research International. 2013 Jan 1;2013.

 

[2] [2] Vardanyan R, Hruby V. Synthesis of best-seller drugs. Academic press; 2016 Jan 7.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

two × one =

×
PG Diploma in Advance Clinical Research 2020
Apply now

Developed By Connect Globes